Tag: SCAI 2026
New data link tirzepatide to greatly reduced cardiovascular risk in high-risk patients undergoing cardiac procedures
Two new studies show that GLP-1-based drug tirzepatide significantly reduces cardiovascular risk...
STEMI patients with COVID-19 were 67% more likely to die at one year than those without coronavirus, registry reveals
Findings from the North American COVID-19 myocardial infarction (NACMI) registry demonstrate sig...
